• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

翻译后修饰在阿尔茨海默病中的作用

The Involvement of Post-Translational Modifications in Alzheimer's Disease.

作者信息

Marcelli Serena, Corbo Massimo, Iannuzzi Filomena, Negri Lucia, Blandini Fabio, Nistico Robert, Feligioni Marco

机构信息

Laboratory of Pharmacology of Synaptic Disease, EBRI Rita Levi-Montalcini Foundation, Rome, Italy.

Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.

出版信息

Curr Alzheimer Res. 2018 Feb 22;15(4):313-335. doi: 10.2174/1567205014666170505095109.

DOI:10.2174/1567205014666170505095109
PMID:28474569
Abstract

BACKGROUND

Alzheimer's disease (AD) is a neurodegenerative disorder recognized as the most common cause of chronic dementia among the ageing population. AD is histopathologically characterized by progressive loss of neurons and deposits of insoluble proteins, primarily composed of amyloid-β pelaques and neurofibrillary tangles (NFTs).

METHODS

Several molecular processes contribute to the formation of AD cellular hallmarks. Among them, post-translational modifications (PTMs) represent an attractive mechanism underlying the formation of covalent bonds between chemical groups/peptides to target proteins, which ultimately result modified in their function. Most of the proteins related to AD undergo PTMs. Several recent studies show that AD-related proteins like APP, Aβ, tau, BACE1 undergo post-translational modifications. The effect of PTMs contributes to the normal function of cells, although aberrant protein modification, which may depend on many factors, can drive the onset or support the development of AD.

RESULTS

Here we will discuss the effect of several PTMs on the functionality of AD-related proteins potentially contributing to the development of AD pathology.

CONCLUSION

We will consider the role of Ubiquitination, Phosphorylation, SUMOylation, Acetylation and Nitrosylation on specific AD-related proteins and, more interestingly, the possible interactions that may occur between such different PTMs.

摘要

背景

阿尔茨海默病(AD)是一种神经退行性疾病,被认为是老年人群中慢性痴呆最常见的病因。AD的组织病理学特征是神经元逐渐丧失以及不溶性蛋白质沉积,主要由β-淀粉样蛋白斑块和神经原纤维缠结(NFTs)组成。

方法

多种分子过程促成了AD细胞特征的形成。其中,翻译后修饰(PTM)是一种有吸引力的机制,它是化学基团/肽与靶蛋白之间形成共价键的基础,最终导致其功能发生改变。大多数与AD相关的蛋白质都会经历PTM。最近的几项研究表明,与AD相关的蛋白质,如APP、Aβ、tau、BACE1都会发生翻译后修饰。PTM的作用有助于细胞的正常功能,尽管异常的蛋白质修饰(可能取决于多种因素)会引发AD的发病或促进其发展。

结果

在这里,我们将讨论几种PTM对AD相关蛋白质功能的影响,这些影响可能促成AD病理学的发展。

结论

我们将考虑泛素化、磷酸化、SUMO化、乙酰化和亚硝基化对特定AD相关蛋白质的作用,更有趣的是,考虑这些不同PTM之间可能发生的相互作用。

相似文献

1
The Involvement of Post-Translational Modifications in Alzheimer's Disease.翻译后修饰在阿尔茨海默病中的作用
Curr Alzheimer Res. 2018 Feb 22;15(4):313-335. doi: 10.2174/1567205014666170505095109.
2
Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.靶向tau蛋白的翻译后修饰作为阿尔茨海默病的治疗策略。
J Neurogenet. 2011 Dec;25(4):127-33. doi: 10.3109/01677063.2011.626471.
3
[Alzheimer disease: cellular and molecular aspects].[阿尔茨海默病:细胞与分子层面]
Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1.
4
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
5
The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer's Disease.翻译后修饰在调控阿尔茨海默病的发生发展中的作用
Mol Neurobiol. 2023 Jul;60(7):3617-3632. doi: 10.1007/s12035-023-03277-z. Epub 2023 Mar 6.
6
Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry.通过质谱分析阿尔茨海默病的翻译后修饰。
Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):2040-2047. doi: 10.1016/j.bbadis.2018.11.002. Epub 2018 Nov 24.
7
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.Tau蛋白的翻译后修饰及其在阿尔茨海默病病理学中的作用。
Curr Alzheimer Res. 2024;21(1):24-49. doi: 10.2174/0115672050301407240408033046.
8
SUMO and Alzheimer's disease.SUMO 与阿尔茨海默病。
Neuromolecular Med. 2013 Dec;15(4):720-36. doi: 10.1007/s12017-013-8257-7. Epub 2013 Aug 25.
9
Selectively increased oxidative modifications mapped to detergent-insoluble forms of Abeta and beta-III tubulin in Alzheimer's disease.在阿尔茨海默病中,选择性增加的氧化修饰定位于不溶性去污剂形式的β淀粉样蛋白(Aβ)和βIII微管蛋白。
FASEB J. 2006 Jul;20(9):1473-83. doi: 10.1096/fj.06-5920com.
10
A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.一种翻译后修饰特征定义了可溶性tau 的变化,这些变化与早期阿尔茨海默病大脑中的寡聚化相关。
Acta Neuropathol Commun. 2019 Dec 3;7(1):192. doi: 10.1186/s40478-019-0823-2.

引用本文的文献

1
Decoding the role of glucocorticoid-regulated kinase 1 in Alzheimer's disease: a promising path toward novel therapeutic strategies.解读糖皮质激素调节激酶1在阿尔茨海默病中的作用:通向新型治疗策略的一条充满希望的途径。
Inflammopharmacology. 2025 May 15. doi: 10.1007/s10787-025-01777-z.
2
Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration.tau蛋白过度磷酸化在糖尿病视网膜神经退行性变中的作用
J Ophthalmol. 2025 Mar 12;2025:3278794. doi: 10.1155/joph/3278794. eCollection 2025.
3
Inhibition of zDHHC7-driven protein S-palmitoylation prevents cognitive deficits in an experimental model of Alzheimer's disease.
抑制 zDHHC7 驱动的蛋白质 S-棕榈酰化可预防阿尔茨海默病实验模型中的认知障碍。
Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2402604121. doi: 10.1073/pnas.2402604121. Epub 2024 Nov 26.
4
DiscoverPath: A Knowledge Refinement and Retrieval System for Interdisciplinarity on Biomedical Research.发现路径:一个用于生物医学研究跨学科性的知识提炼与检索系统。
Proc ACM Int Conf Inf Knowl Manag. 2023 Oct;2023:5021-5025. doi: 10.1145/3583780.3614739. Epub 2023 Oct 21.
5
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.Tau蛋白的翻译后修饰及其在阿尔茨海默病病理学中的作用。
Curr Alzheimer Res. 2024;21(1):24-49. doi: 10.2174/0115672050301407240408033046.
6
An approach to identify potential downstream targets of miR-153 involved in Alzheimer's disease.一种识别参与阿尔茨海默病的miR-153潜在下游靶点的方法。
Front Genet. 2024 Jan 16;15:1271404. doi: 10.3389/fgene.2024.1271404. eCollection 2024.
7
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.死亡相关蛋白激酶 1 作为阿尔茨海默病的治疗靶点。
Transl Neurodegener. 2024 Jan 9;13(1):4. doi: 10.1186/s40035-023-00395-5.
8
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer's disease.miR-155 在阿尔茨海默病不可变和可改变风险因素中的发病机制。
Alzheimers Res Ther. 2023 Jul 14;15(1):122. doi: 10.1186/s13195-023-01264-z.
9
Sex specific molecular networks and key drivers of Alzheimer's disease.性别特异性分子网络与阿尔茨海默病的关键驱动因素。
Mol Neurodegener. 2023 Jun 20;18(1):39. doi: 10.1186/s13024-023-00624-5.
10
Exploration and Clinical Verification of the Blood Co-Expression Genes of Type 2 Diabetes Mellitus and Mild Cognitive Dysfunction in the Elderly.老年2型糖尿病与轻度认知功能障碍血液共表达基因的探索与临床验证
Biomedicines. 2023 Mar 23;11(4):993. doi: 10.3390/biomedicines11040993.